Experience

• 

  Pharco Pharmaceuticals

  • Egypt

  • Marketing Director

    • Jul 2023 - Present
    • Egypt
• 

  Amriya for Pharmaceutical Industries S.A.E

  • Business Unit Director

    • Jul 2020 - Present
• 

  Boehringer Ingelheim

  • Cairo Governorate, Egypt

  • Business Unit Head

    • May 2019 - Jun 2020
    • Cairo Governorate, Egypt
• 

  Hygint Pharmaceutical Company

  • Marketing Director

    • Feb 2019 - May 2019
• 

  Delta Pharma / Pharaonia Pharmaceuticals

  • Egypt

  • Group strategic planning consultant

    • May 2018 - Oct 2018
    • Egypt
• 

  Pfizer

  • Therapeutic Area Director

    • Jan 2014 - Apr 2018

  • Business Unit Director

    • Jun 2013 - Jan 2014

  • Business Unit Manager

    • Jan 2012 - Jun 2013

    Area of responsibility: Specialty & Oncology Business Unit Market: Egypt

  • Marketing Manager

    • Jan 2010 - Dec 2011

  • Senior Product Manager

    • Feb 2009 - Jan 2010

    Area of responsibility: CHAMPIXMarket: Kingdom of Saudi Arabia 1- CHAMPIX successful launch in KSA a. CHAMPIX KSA representing 50 % of total Africa Middle East Regionb. KSA ranked 2nd country worldwide in term of product performance c. Development & execution of strong PR & DTC campaign ( I Quit) leading to the Highest level of product public awareness across AFME Region confirmed by IMS market research D- the 1st successful Partnership Program with MOH Smoking Cessation Program in KSA & Middle East

  • Regional Product Manager

    • May 2002 - Feb 2009

    Area of Responsibility: CHAMPIX, ZITHROMAX, Outsourcing Project (Dalacin, Cefobid & Vibramycin)Markets: Egypt, Levant region, Gulf & KSA Successful Product launches:Through the last 10 years in Pfizer I was responsible for launching / or Re-Launching wide range of products in different markets:1- Zirhtomax IV Launch :Jordan Feb., 20032- Zithromax Launch : Syria Aug., 20033- Zithromax IV launch: Egypt March 20044- Dalacin C Re-launch : Egypt June 20055- Dalacin T/ Dalacin V Re-launch: Egypt March 20066- Champix : KSA Aug., 2008B) Products’ Performance1- Zithromax showed Double Digit Growth in Egypt & Gulf Areas for consecutive 5 years starting form 2001 till 2006 2- Increasing Zithromax revenue & Market position to be ranked among top 10 Antibiotics in the total Abs Market.3- Successful Re-Launch of Dalacin Range “ C, T & V forms” a. Product range meet the company sales objective b. Rapid penetration of Macrolide & total Antibiotics market as well4- Champix: as mentioned above Parallel Responsibilities form Dec., 2007 – Present:1- CHAMPIX Area Commercial Team for Africa Middle East Region representing KSA & Gulf Region 2- Viagra Area Commercial Team for Africa Middle East Region representing KSA & Egypt Key responsibilities:• Increase ability to manage brands by increasing collaboration & support for different Market in the AFME • Share best practices across the region• Realize scale efficiencies across the region • Improve speed of decision-making

  • Assistant Product manager

    • Jan 1999 - May 2002

    Area of Responsibility: ZITHROMAXMarket: Egypt & Levant Region

  • Cardiovascular Product Specialist

    • Dec 1996 - Dec 1998

    Product Range: Norvasc & Lipitor Achievements:Lipitor achieved highest SOM in my territory Norvasc achieved highest growth in market share Both products achieved their financial goals

  • Professional Medical Representative

    • Mar 1995 - Nov 1996

  • Medical Representative

    • Mar 1994 - Feb 1995

    Achievements:Pfizer Super Star Award for 1994